Scarica l'app Stockscreener
1.06
11.67%
-0.14
Dopo l'orario di chiusura:
1.09
0.03
+2.83%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTSO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.20
Aprire:
$1.15
Volume 24 ore:
170.51K
Relative Volume:
1.00
Capitalizzazione di mercato:
$66.53M
Reddito:
$33.79M
Utile/perdita netta:
$-18.67M
Rapporto P/E:
-2.9592
EPS:
-0.3582
Flusso di cassa netto:
$-19.17M
1 W Prestazione:
+15.85%
1M Prestazione:
+0.00%
6M Prestazione:
-7.83%
1 anno Prestazione:
+18.94%
Intervallo 1D:
$1.06
$1.179
Intervallo di 1 settimana:
$0.8754
$1.22
Portata 52W:
$0.7101
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
Nome
Cytosorbents Corp
Settore
Industria
Telefono
973-329-8885
Indirizzo
305 COLLEGE ROAD EAST, PRINCETON, NJ
Confronta CTSO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
1.06 | 62.61M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
131.02 | 233.71B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.64 | 152.83B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.61 | 144.35B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.08 | 119.00B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.93 | 46.00B | 5.69B | 4.14B | 577.90M | 6.96 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-07 | Iniziato | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2020-09-17 | Iniziato | Jefferies | Buy |
| 2020-09-01 | Iniziato | SVB Leerink | Outperform |
| 2017-08-08 | Reiterato | Maxim Group | Buy |
| 2016-10-26 | Iniziato | Aegis Capital | Buy |
| 2016-05-24 | Iniziato | Maxim Group | Buy |
| 2015-10-29 | Aggiornamento | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | Reiterato | MLV & Co | Buy |
| 2015-04-01 | Reiterato | MLV & Co | Buy |
| 2015-03-05 | Iniziato | MLV & Co | Buy |
| 2015-02-25 | Iniziato | WBB Securities | Speculative Buy |
| 2015-01-27 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Cytosorbents Corp Borsa (CTSO) Ultime notizie
Is this a good reentry point in Cytosorbents CorporationFree Daily Chart Pattern Stock Forecast - Newser
Cytosorbents Corporation (NASDAQ:CTSO) Q2 2025 Earnings Call Transcript - Insider Monkey
Exit strategy if you’re trapped in Cytosorbents CorporationEquity Market Return Forecast Model Update - Newser
Can volume confirm reversal in Cytosorbents CorporationExit Strategy Guide With Risk Control Plan - Newser
What institutions are buying Cytosorbents Corporation stock now5-Year Price Trend Summary and Analysis - Newser
How sentiment analysis helps forecast Cytosorbents CorporationSummary of Trade Cycles in 5-Year Range - Newser
Is Cytosorbents Corporation reversing from oversold territorySwing Trade Planning with Consistent Setup - Newser
Will Cytosorbents Corporation continue its uptrendFree Long Hold Safe Return Strategy - Newser
Cytosorbents’ (CTSO) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Reversal indicators forming on Cytosorbents Corporation stockTechnical Safety Zone Pattern Recognition - Newser
How to forecast Cytosorbents Corporation trends using time seriesHigh Return Strategy with Low Risk - Newser
How Cytosorbents Corporation stock performs during market volatilityTechnical Screener for High Growth Stocks - Newser
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips By Investing.com - Investing.com Canada
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips - Investing.com
CytoSorbents Corp (CTSO) Q2 2025 Earnings Call Highlights: Strat - GuruFocus
CytoSorbents Reports Positive Q2 2025 Financial Results - TipRanks
Cytosorbents Corp reports results for the quarter ended June 30Earnings Summary - TradingView
CytoSorbents: Q2 Earnings Snapshot - San Antonio Express-News
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire
What MACD signals say about Cytosorbents CorporationWeekly Market Direction and Sector Summary - Newser
Why Cytosorbents Corporation stock attracts strong analyst attentionFree Pattern Detection for Entry Confirmation - Newser
Cytosorbents Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
How to recover losses in Cytosorbents Corporation stockBuy and Hold Return Summary with Charts - Newser
Tools to assess Cytosorbents Corporation’s risk profileFree Real Time Alerts Based on AI Prediction - Newser
Is Cytosorbents Corporation stock overvalued or undervaluedAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is it the right time to buy Cytosorbents Corporation stockBuild a portfolio that delivers consistent profits - Jammu Links News
Breakthrough Sepsis Treatment: CytoSorb Therapy Achieves 70% Survival Rate in Latest Clinical Studies - Stock Titan
CytoSorbents Leads a New Era in Sepsis Treatment - Nasdaq
What makes Cytosorbents Corporation stock price move sharplyWeekly High Conviction Trade Setup Analysis - Newser
Should you wait for a breakout in Cytosorbents CorporationFree Wealth Building Stock Market Ideas - Newser
Medical Tech Leader CytoSorbents Sets Q2 2025 Earnings Call: Key Updates Expected on ICU Treatment Solutions - Stock Titan
Why is Cytosorbents Corporation stock attracting strong analyst attentionHigh-profit stock alerts - Jammu Links News
Is Cytosorbents Corporation a growth stock or a value stockAchieve consistent double-digit returns - Jammu Links News
What are the latest earnings results for Cytosorbents CorporationUnlock powerful insights from market experts - Jammu Links News
Is Cytosorbents Corporation stock a good hedge against inflationAccelerated financial growth - jammulinksnews.com
What analysts say about Cytosorbents Corporation stockUnmatched market performance - jammulinksnews.com
Cytosorbents Corp Azioni (CTSO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cytosorbents Corp Azioni (CTSO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| MARIANI PETER J | Chief Financial Officer |
Dec 12 '24 |
Buy |
0.89 |
20,000 |
17,872 |
381,363 |
| MARIANI PETER J | Chief Financial Officer |
Dec 11 '24 |
Buy |
0.89 |
11,363 |
10,103 |
361,363 |
1.57%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):